PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer
Advanced Science · 2025-07 · 12 (27)
DOI: 10.1002/advs.202500271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.05.2025. Verfasst von Jiang Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xiangya Hospital, 87 Xiangya Road, Kaifu District, Central South University, Changsha, Hunan, 410008, P. R. China. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Colorectal Neoplasms, DNA Mismatch Repair. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Hunan Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Microsatellite stable (MSS) colorectal cancer (CRC) is considered an “immune‐cold” tumor, accounting for ≈85% of all CRC cases. The overall response rate to chemotherapy combined with immune checkpoint inhibitors in MSS CRC is typically less than 10%. The specific mechanism that enhances chemotherapy sensitivity and mediated immunogenicity renders MSS CRC more responsive to immunotherapy remains elusive. Experiments in this study identify a DNA damage repair‐related epigenetic gene, protein arginine methyltransferase 5 (PRMT5), whose inhibition enhances Irinotecan (CPT‐11) sensitivity and synergistically induces a postmeiotic segregation increased 2 (PMS2)‐deficient‐like state, leading to the release of cytosolic double‐stranded DNA. This activates the cyclic GMP‐AMP synthase (cGAS)‐stimulator of the IFN gene (STING) signaling pathway, thereby enhancing anti‐tumor immunotherapy through dendritic cell‐T cell‐dependent functions. Importantly, combining the epigenetic anti‐tumor drug GSK3326595 with CPT‐11 significantly upregulates the immune receptor tyrosine‐based inhibitory motif (TIGIT) level on CD8+ T cells and subsequently demonstrates impressive anti‐tumor efficacy in vivo when additional anti‐TIGIT is included. Collectively, this study reveals the crucial role of PRMT5 blockade combined with CPT‐11 in inducing a mismatch repair deficiency‐like state and provides a novel triple‐drug combination therapy strategy as a potential treatment for patients with MSS CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Xiangya Hospital, 87 Xiangya Road, Kaifu District, Central South University, Changsha, Hunan, 410008, P. R. China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, 87 Xiangya Road, Kaifu District, Central South University, Changsha, Hunan, 410008, P. R. China.
- Department of Nephrology, Xingsha Campus, Hunan Provincial People's Hospital, Changsha, Hunan, 410100, P. R. China.
- College of Life Science, Mudanjiang Medical University, Mudanjiang, 157011, P. R. China.
- Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.
ORCID-Profile: Ying Han
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Hunan Province
- Nature Science Foundation of Changsha
- CSCO Cancer Research Foundation
Zitieren
APA
Zhu, J., Fu, S., Zou, X., Zeng, H., Cui, G., Peng, Y., Tang, D., Zhang, F., Shen, H., Zeng, S., & Han, Y. (2025). PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer. Advanced Science, 12(27). https://doi.org/10.1002/advs.202500271
Vancouver
Zhu J, Fu S, Zou X, Zeng H, Cui G, Peng Y, et al. PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer. Advanced Science. 2025;12(27). doi:10.1002/advs.202500271
BibTeX
@article{Zhu2025,
author = {Zhu, Jiang and Fu, Shenao and Zou, Xi and Zeng, Hanjiang and Cui, Guangzu and Peng, Yinghui and Tang, Diya and Zhang, Fan and Shen, Hong and Zeng, Shan and Han, Ying},
title = {PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {27},
doi = {10.1002/advs.202500271}
}
EUVIMED